CAAS Capital Management’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-557,967
Closed -$28M 1367
2021
Q1
$28M Buy
557,967
+384,906
+222% +$26.2M 0.3% 65
2020
Q4
$15.5M Buy
173,061
+158,061
+1,054% +$13.3M 0.15% 143
2020
Q3
$1.15M Buy
+15,000
New +$953K 0.03% 325

Other funds holding CELL

CAAS Capital Management's CELL Position: Q2 2021 in Review

CAAS Capital Management sold out of PhenomeX Inc. Common Stock (CELL) in Q2 2021, closing a stake of 557,967 shares — an estimated $28M sold.

CAAS Capital Management first reported a position in CELL in Q3 2020 and held it in 3 quarters. The position peaked at $28M in Q1 2021. 156 funds tracked by Wall St. Rank hold CELL as of Q2 2021.

  • CAAS Capital Management reported no remaining PhenomeX Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • CAAS Capital Management sold 557,967 PhenomeX Inc. Common Stock shares in Q2 2021, an estimated $28M.
  • CAAS Capital Management first reported a position in PhenomeX Inc. Common Stock in Q3 2020 and held it in 3 quarters.
  • CAAS Capital Management's PhenomeX Inc. Common Stock position peaked at $28M in Q1 2021.
  • 156 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q2 2021.

Based on CAAS Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.